AMWL241220P5000
- 0.00
- 0.000.00%
American Well Newsroom
Truist Financial Maintains American Well(AMWL.US) With Hold Rating
Piper Sandler Maintains American Well(AMWL.US) With Hold Rating, Maintains Target Price $10
Piper Sandler Reaffirms Their Hold Rating on American Well (AMWL)
A Quick Look at Today's Ratings for American Well(AMWL.US), With a Forecast Between $12 to $20
American Well Analyst Ratings
Truist Financial Maintains American Well(AMWL.US) With Hold Rating
Truist Financial Keeps Their Hold Rating on American Well (AMWL)
Stifel Nicolaus Sticks to Their Hold Rating for American Well (AMWL)
TD Cowen Maintains American Well(AMWL.US) With Hold Rating, Maintains Target Price $12
A Quick Look at Today's Ratings for American Well(AMWL.US), With a Forecast Between $12 to $20
American Well Analyst Ratings
American Well: Strategic DHA Contract Acknowledged Amid Hold Rating Pending Execution Proof
Analysts Conflicted on These Healthcare Names: American Well (AMWL), Cogent Biosciences (COGT) and NeoGenomics (NEO)
American Well: Hold Rating Amidst SaaS Deployment With DHA and Projected Financial Improvements
Truist Financial Maintains American Well(AMWL.US) With Hold Rating
American Well (AMWL) Gets a Hold From Truist Financial
American Well Analyst Ratings
American Well: Hold Rating Affirmed Amid Cost Management Improvements and Revenue Growth Challenges
Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals Ltd. (OtherTLPPF) and American Well (AMWL)
Wells Fargo Maintains American Well(AMWL.US) With Hold Rating, Cuts Target Price to $15